ORTEXORTEX News
Tracking JPM? Get live short interest, options flow, and signals on ORTEX.Sign up free →
JP
Trader NoteJPM

JPM Finds Footing Above $335 as Peers Run Ahead

By ORTEX News · Edited by , Editor, ORTEX NewsUpdated 3 min readdata as of 28 Oct 2026, 18:24

Produced automatically from ORTEX data and published under the ORTEX News editorial standards set by Peter Hillerberg, Editor, ORTEX News. How we publish

ShareXLinkedInReddit

JPMorgan Chase has stabilised this week after last week's full round-trip of its post-earnings gain, closing at $335.79 with a modest recovery of roughly 0.2% on the week, but the broader peer group is moving faster and the valuation gap to consensus remains wide open.

The most telling signal this week is relative performance. PNC Financial Services gained nearly 3% on the week, Citizens Financial added 1.7%, and U.S. Bancorp rose 1.1%. JPM's 0.16% weekly gain sits at the bottom of that table. The stock is back above where it closed on earnings day on October 13, but only barely, and the Street mean price target of $372.26 still implies roughly 11% upside from current levels. That gap has now been open for two consecutive weeks without the stock making meaningful progress toward closing it.

Options positioning has eased slightly from where it stood earlier in the month, but investors are not fully relaxed. The put/call ratio is running at 1.11, above its 20-day average of 1.06 by just under one standard deviation. That is a step down from the more defensive readings of mid-October, when the PCR was closer to 1.15 and the z-score pushed above 1.7, suggesting some of the post-earnings caution has unwound. The borrow market adds nothing to the story: availability is essentially unconstrained, short interest is under 1% of the free float at 0.97%, and cost to borrow is 0.34%. Short sellers are not a factor here in any direction.

The Street is broadly constructive but with an important caveat on price. The cluster of analyst moves following the October 13 earnings release was mostly positive: Barclays lifted its target to $425, Morgan Stanley moved to $377, and RBC reiterated Outperform at $370. Citigroup was the outlier, trimming to $350 and holding Neutral. The analyst recommendation spread sits in the 97th percentile of the universe, meaning JPM is among the most positively rated stocks tracked. Valuation multiples, however, have drifted. The P/E is 13.3, down roughly 0.3 points over the past 30 days. Price-to-book is at 2.27, also softer on the month. That compression happened while the Q3 results were objectively strong: managed revenue of $50.9 billion, net income of $15.3 billion, and a 20% ROTCE. The bear case centres on the one-time nature of some of those gains, rising noninterest expense of $27.3 billion, and the risk of credit deterioration into a potential 2027 slowdown.

FDIC call report data tracked by ORTEX provides useful background colour on the underlying balance sheet trajectory, though the dataset does not yet have enough history to establish a measured lead against JPM's reported figures. What the data does show, as stated facts: net loans and leases have risen for nine consecutive quarters, reaching $1.54 trillion as of the April 2026 period, and total deposits have grown for three consecutive quarters to $2.82 trillion. Those streaks describe a lending book that has expanded without interruption through the current rate cycle, which is consistent with the bull case but does not resolve the question of whether NII growth is durable at lower rates.

Retail attention remains elevated. The Wikipedia views signal is running at a z-score of 2.3 as of October 21, a reading that has persisted since the earnings release. That kind of sustained retail interest often fades quickly after a results cycle and the degree to which it persists into November will be worth watching as the stock either closes its discount to consensus or settles into a new, lower range ahead of the January 14 Q4 report.

Stocks in this article

See the live data behind this article on ORTEX.

Open JPM on ORTEX →

How this article was generated

Generated
28 Oct 2026, 18:24
Data as of
28 Oct 2026, 18:24
Prompt version
v1.0
Data sources
Short interestCost to borrowUtilizationOptions flowEarningsAnalyst consensusInstitutional positioningORTEX Alpha signalsRecent ORTEX notesAlt DataPrevious Mi Articles

ORTEX Market Intelligence content is generated by AI from a snapshot of ORTEX's proprietary data and reviewed by the ORTEX team. Content is informational only and does not constitute investment advice.